FDA Approves Novartis's Afinitor Tablets To Treat Patients With Kidney Tumors NASDAQ (RTTNews.com) - Novartis Pharmaceuticals Corp., an affiliate of Novartis AG (NVS), announced today that the US Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal ... |
